Morrisville-based Centice, a Duke University spin-out that makes and sells a computerized sensor-based drug verification system for safer dispensing of medicines, has raised another $6.1 million, this time in Series C financing.
After winning the Duke Start-Up Challenge compeition, Centice was incorporated in 2004 and now is commercializing its PASS Rx pharmaceutical authentication sensor system.
Centice closed a $3 million A round in 2004 and secured an $11.3 million second round of financing in November 2007.
The new investment added Fulcrum Financial Group of Raleigh to the previous supporters: Cary-based Aurora Funds, S-Group Direct Investments, Innovation Ventures and several individual investors.